The End of the Second Series
One hundred articles, following one hundred before them. The second series concludes—not because the nicotine story is resolved, but because every inquiry must have an ending. The work continues.
This is the final article of the second series of 100—following the first 100, and the original 10 that preceded them. Over 200 articles in total. The nicotine landscape has been mapped from every angle. The evidence has been presented. The arguments have been examined. The voices of the excluded have been amplified. The work is not complete—it never will be—but the series must end.
What remains? The evidence will continue to accumulate. The policies will continue to be debated. The products will continue to evolve. The mortality will continue—7 million annually, declining slowly, concentrated among the poor. The gap between what we know and what we do will continue to be the central tragedy of the nicotine epidemic. And the people working to close that gap—researchers, advocates, policymakers, nicotine users themselves—will continue their work.
This series has been an attempt to contribute to that work. To provide the evidence, the analysis, and the human context that might help readers navigate the most consequential public health debate of our time. Whether it succeeded is for you to judge. The series ends. The story continues. The next chapter is yours.
